EyePoint Pharmaceuticals Inc. (EYPT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    EyePoint Pharmaceuticals ...

    NASDAQ: EYPT · Real-Time Price · USD
    14.01
    2.13 (17.93%)
    At close: Sep 05, 2025, 3:59 PM
    14.00
    -0.07%
    Pre-market: Sep 08, 2025, 05:10 AM EDT

    EyePoint Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 43.27M 46.02M 41.4M 36.94M
    Cost of Revenue
    		 3.71M 4.63M 8.33M 8.18M
    Gross Profit
    		 39.56M 41.39M 33.08M 28.76M
    Operating Income
    		 -145.85M -75.07M -78.94M -55.28M
    Interest Income
    		 15.09M 6.95M 2.13M 292K
    Pretax Income
    		 -130.78M -70.71M -102.25M -58.42M
    Net Income
    		 -130.87M -70.8M -124.51M -63.91M
    Selling & General & Admin
    		 52.49M 51.79M 60.32M 53.08M
    Research & Development
    		 132.93M 64.66M 49.64M 28.5M
    Other Expenses
    		 n/a n/a 2.05M 2.46M
    Operating Expenses
    		 185.41M 115.05M 112.02M 84.04M
    Interest Expense
    		 14K 1.25M 3.19M 5.5M
    Selling & Marketing Expenses
    		 131K 11.69M 25.51M 27.5M
    Cost & Expenses
    		 189.13M 121.08M 120.34M 92.22M
    Income Tax Expense
    		 90K 83K 22.26M 5.5M
    Shares Outstanding (Basic)
    		 56.3M 38.9M 37.32M 28.76M
    Shares Outstanding (Diluted)
    		 56.3M 38.9M 37.32M 28.76M
    EPS (Basic)
    		 -2.32 -1.82 -3.34 -2.22
    EPS (Diluted)
    		 -2.32 -1.82 -3.34 -2.22
    EBITDA
    		 -129.23M -69M -96.62M -50.15M
    EBIT
    		 -130.77M -69.47M -99.06M -52.92M
    Depreciation & Amortization
    		 1.54M 464K 2.45M 2.77M

    Add to Watchlist